On March 23, 2020, Wen Daxiang, Director of the Municipal Supervision Bureau, Li Jie, Director of the Drug Registration Office, Shi Lan, Director of the Drug Supervision Department, and other relevant personnel came to AVT to investigate.
On behalf of the company, the general manager Dr. Cao Liang expressed a warm welcome to the research team and introduced the general overview of AVT and the main business content in detail. He conducted in-depth exchanges on current development and planning issues of AVT, and sought guidance from the research team.
Director Wen highly praised and fully affirmed the development of AVT, and encouraged us to continue to develop unremittingly. As a pharmaceutical excipient company, AVT pays close attention to industry dynamics in time, especially various laws and regulations, such as "Pharmaceuticals" "Regulations on Registration Management, Draft for Comments", put forward enterprise opinions on this and promote the development of the industry.
Director Wen said that as a regulatory agency, Shanghai Drug Administration is working hard to provide beneficial assistance for the development of enterprises.